NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tirzepatide from Zhuoyue Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
+3 more ↓
67%
Finnrick rating
#266 of 281 Tirzepatide vendors
10 of 17 classifiable tests passed
natural 59% · customers 4.6★ (8)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Zhuoyue Tirzepatide shows a volatile evidence pattern, with purity misses as low as 98.18%, two identity failures, and overfills up to +120%. Recent cleaner results point to a recovery, but consistency is the next thing to scrutinize.

methodology →
vendor intelligence report
Vendor Intelligence Report: Zhuoyue Biotechnology

A website-disclosed Wyoming LLC, privacy-masked domain records, and a China-side registry signal do not resolve to a clear operating laboratory. The report also maps a shared WhatsApp trail into unrelated gray-market selling and self-issued COAs with unsupported regulatory language.

22 pages6 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.11
89%
6
2
Retatrutide
$1.10
85%
14
3
Tirzepatideselected
$0.55
67%
17
4
TB-500
$1.80
33%
3
6
KLOW
-
-
0
7
MOTS-c
-
-
0
8
NAD+
-
-
0
9
Semaglutide
$0.66
-
0
10
SS-31
-
-
0
11
Tesamorelin
$2.45
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Nov 2025: 74%19 Jan 2026: 77%29 Jan 2026: 79%13 Feb 2026: 79%4 Mar 2026: 73%4 Mar 2026: 69%4 Mar 2026: 66%4 Mar 2026: 67%25 Mar 2026: 68%25 Mar 2026: 65%2 May 2026: 62%8 May 2026: 64%16 Jun 2026: 66%13 Jul 2026: 63%14 Jul 2026: 64%2 Aug 2026: 65%27 Oct 2026: 67%15 Nov 2026: current 67%74%68%67%Nov 25Nov 26
Showing Tirzepatide tests only
Peptide testing

Ordered Tirzepatide from Zhuoyue Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply
Zhuoyue Biotechnology Tirzepatide test history
COA-backed lab tests
1-10 of 17

About Zhuoyue Biotechnology test results from Finnrick

Zhuoyue Biotechnology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 40 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Zhuoyue Biotechnology peptides in this dataset are GHK-Cu (6 tests), Retatrutide (14 tests) and TB-500 (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 40 recent tests. It also includes 1 correction related to this vendor.

Corrections
2026-09-02
Finnrick data entry
GHK-Cu (Zhuoyue Biotechnology): stated amount corrected from 100 mg to 50 mg.
Peptide testing

Ordered Tirzepatide from Zhuoyue Biotechnology? Mail in a sample (US only) and let us test it.

Test my supply